Here are today’s upgrades and downgrades: Novo Nordisk, Weyerhaeuser, Applied Therapeutics, PotlatchDeltic and more.
This Top-Notch Stock is a Solid Choice Right Now
by
•It has a lot of positives going for it…
3 Top Ranked Stocks to Buy for 2025
by
•All with strong fundamentals, each of these names is positioned to perform well under different potential scenarios for the coming year.
How to Protect Yourself From a Crash and Get 11% a Year (Paid Monthly)
by
•It pays a double-digit yield that is on solid footing, and looks to be for several more years.
This Stock Looks Ready for a Breakout in the Short-Term
by
•Our target potential upside is 13%-27% in the next 3-6 months.
Upgrades and Downgrades for Friday, 12/20
by
•Here are today’s upgrades and downgrades: Nike, FedEx, Merck, Biogen, State Street, Kimco Realty, Lennar and more.
This Small-Cap Stock Appears to be Just Getting Started
by
•The company is firing on all cylinders fundamentally, and the technical setup looks to provide a buying opportunity into next year.
Trade This $1 Stock for a 73%-127% Potential Return
by
•It just broke out of a symmetrical triangle pattern.
3 Contrarian Picks for Trump 2.0 (Yields up to 7.5%)
by
•One is a timely buy now, while the two others are solid additions to your “watch list” and ripe for picking up on the next dip.
The Bulls Are Gaining Control of This Breakout Stock
by
•Our target potential upside is 24%-42% in the next 3-6 months.